Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,278 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Synaptic protein CSF levels relate to memory scores in individuals without dementia.
Wesenhagen KEJ, de Leeuw DM, Tomassen J, Gobom J, Bos I, Vos SJB, Martinez-Lage P, Tainta M, Popp J, Peyratout G, Tsolaki M, Vandenberghe R, Freund-Levi Y, Verhey F, Lovestone S, Streffer J, Dobricic V, Blennow K, Scheltens P, Smit AB, Bertram L, Teunissen CE, Zetterberg H, Tijms BM; Alzheimer’s Disease Neuroimaging Initiative. Wesenhagen KEJ, et al. Among authors: scheltens p. Res Sq [Preprint]. 2024 Jul 23:rs.3.rs-4607202. doi: 10.21203/rs.3.rs-4607202/v1. Res Sq. 2024. PMID: 39108495 Free PMC article. Preprint.
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype.
Vermunt L, Sikkes SAM, van den Hout A, Handels R, Bos I, van der Flier WM, Kern S, Ousset PJ, Maruff P, Skoog I, Verhey FRJ, Freund-Levi Y, Tsolaki M, Wallin ÅK, Olde Rikkert M, Soininen H, Spiru L, Zetterberg H, Blennow K, Scheltens P, Muniz-Terrera G, Visser PJ; Alzheimer Disease Neuroimaging Initiative; AIBL Research Group; ICTUS/DSA study groups. Vermunt L, et al. Among authors: scheltens p. Alzheimers Dement. 2019 Jul;15(7):888-898. doi: 10.1016/j.jalz.2019.04.001. Epub 2019 Jun 1. Alzheimers Dement. 2019. PMID: 31164314 Free PMC article.
Cavum Septum Pellucidum (CSP) as a Neuroimaging Signature of Head Impact Exposure compared to Non‐exposed Patients with Neurodegenerative Disease and Controls.
Kamps S, Hempel HL, van Amerongen S, de Bruin H, van der Linden FHC, Barkhof F, Scheltens P, Ossenkoppele R, Vijverberg EGB. Kamps S, et al. Among authors: scheltens p. Alzheimers Dement. 2025 Jan 9;20(Suppl 2):e091209. doi: 10.1002/alz.091209. eCollection 2024 Dec. Alzheimers Dement. 2025. PMID: 39785839 Free PMC article.
Functional Connectivity and Longitudinal Changes in Amyloid Pathology in Cognitively Healthy Older Adults.
ten Kate M, Lorenzini L, Tijms BM, Wink AM, Konijnenberg E, Tomassen J, van der Landen SM, de Geus EJC, Coomans EM, Collij LE, Scheltens P, van de Giessen E, Visser PJ, den Braber A, Barkhof F. ten Kate M, et al. Among authors: scheltens p. Alzheimers Dement. 2025 Jan 9;20(Suppl 2):e088062. doi: 10.1002/alz.088062. eCollection 2024 Dec. Alzheimers Dement. 2025. PMID: 39785529 Free PMC article.
Image‐derived phenotypes in the AMYPAD Prognostic and Natural History Study.
Pieperhoff L, Lorenzini L, Tranfa M, Padrela BE, Ritchie CW, Boada M, Marquié M, Scheltens P, Vandenberghe R, Hanseeuw BJ, Martinez‐Lage P, Payoux P, Stephens AW, Buckley C, Farrar G, Jessen F, Gispert JD, García DV, Mutsaerts HJ, Collij LE, Wink AM, Barkhof F. Pieperhoff L, et al. Among authors: scheltens p. Alzheimers Dement. 2025 Jan 9;20(Suppl 2):e086395. doi: 10.1002/alz.086395. eCollection 2024 Dec. Alzheimers Dement. 2025. PMID: 39784426 Free PMC article.
Image‐derived phenotypes in the AMYPAD Prognostic and Natural History Study.
Pieperhoff L, Lorenzini L, Tranfa M, Padrela BE, Ritchie CW, Boada M, Marquié M, Scheltens P, Vandenberghe R, Hanseeuw BJ, Martinez‐Lage P, Payoux P, Stephens AW, Buckley C, Farrar G, Jessen F, Gispert JD, García DV, Mutsaerts HJ, Collij LE, Wink AM, Barkhof F. Pieperhoff L, et al. Among authors: scheltens p. Alzheimers Dement. 2025 Jan 9;20(Suppl 9):e093686. doi: 10.1002/alz.093686. eCollection 2024 Dec. Alzheimers Dement. 2025. PMID: 39783063 Free PMC article.
Cavum Septum Pellucidum (CSP) as a Neuroimaging Signature of Head Impact Exposure compared to Non‐exposed Patients with Neurodegenerative Disease and Controls.
Kamps S, Hempel HL, van Amerongen S, de Bruin H, van der Linden FHC, Barkhof F, Scheltens P, Ossenkoppele R, Vijverberg EGB. Kamps S, et al. Among authors: scheltens p. Alzheimers Dement. 2025 Jan 9;20(Suppl 9):e093953. doi: 10.1002/alz.093953. eCollection 2024 Dec. Alzheimers Dement. 2025. PMID: 39782999 Free PMC article.
Reasons for screening failure in the evoke and evoke+ trials of semaglutide for early AD.
Sano M, Cummings JL, Feldman HH, Hansson O, van der Flier WM, Bardtrum L, Jeppesen R, Johannsen P, Léon T, Hansen CT, Scheltens P. Sano M, et al. Among authors: scheltens p. Alzheimers Dement. 2025 Jan 9;20(Suppl 6):e088735. doi: 10.1002/alz.088735. eCollection 2024 Dec. Alzheimers Dement. 2025. PMID: 39782639 Free PMC article.
Regional differences in baseline demographic and clinical characteristics from the evoke and evoke+ trials of semaglutide for early Alzheimer’s disease.
van der Flier WM, Scheltens P, Feldman HH, Hansson O, Sano M, Bardtrum L, Johannsen P, Jeppesen R, Hansen CT, Leon T, Cummings JL. van der Flier WM, et al. Among authors: scheltens p. Alzheimers Dement. 2025 Jan 9;20(Suppl 6):e088793. doi: 10.1002/alz.088793. eCollection 2024 Dec. Alzheimers Dement. 2025. PMID: 39782588 Free PMC article.
1,278 results